ActivistsInvestorsTrumpPoliticiansSerenityCitriniBurrySemianalysisSwingTradeArbitrageSearch

Michael & Susan Dell Foundation (auto-surfaced)

cloneable · 31-MAR-2026 → 30-JUN-2026

AUM $3,792,001,723 · 7 positions · top-10 100.0% · SEC filing history →

13FScore 85/100 — cloning their disclosed top holdings over ~4.9y returned +23%/yr vs S&P +11%/yr (alpha +12%/yr), ahead of the market in 55% of quarters. Cloneable 13F equity book only — excludes hedges/shorts/non-US.

New positions

Issuer% bookValueSince entryConvictionBusinessTags
none

Added to (≥+25% shares)

Issuer% bookΔ sharesSince addConvictionBusinessTags
none

Top holdings now

Issuer% bookSince entryBusinessTags
$IVV · iShares Core S&P 500 ETF63.0%+34% Q3 '24iShares Core S&P 500 ETF
$DELL · DELL TECHNOLOGIES INC28.0%+311% Q4 '24Designs and sells personal computers, servers, storage, and networking hardware, plus related software and IT infrastructure services for consumers and enterprises.S&PCitriniBitget →
$AVGO · BROADCOM INC5.1%+208% Q4 '23Broadcom designs semiconductors for networking, broadband, wireless, and storage markets and provides enterprise infrastructure software, including VMware.NASDAQS&PSerenityBitget →
$HAYW · HAYWARD HLDGS INC2.0%-23% Q3 '24Designs and manufactures residential and commercial swimming-pool and outdoor-living equipment, including pumps, filters, heaters and automation systems.
$VTI · VANGUARDTOTALSTOCKMARKETETF · TOTAL STK MKT1.3%+13% Q4 '25VANGUARDTOTALSTOCKMARKETETF · TOTAL STK MKT — exchange-traded fund, filed by 13F managers under class “TOTAL STK MKT”, registrant “VANGUARDTOTALSTOCKMARKETETF”.
$ARCC · ARES CAPITAL CORP0.7%-6% Q4 '25Business development company (middle-market lending)NASDAQ
$CAI · CARIS LIFE SCIENCES INC0.0%+18% Q4 '25Caris Life Sciences is a molecular-science and precision-medicine company offering comprehensive tumor genomic profiling and AI-driven diagnostics to guide cancer treatment.NASDAQ

Since entry / add = price change to the latest close (30-JUN-2026 book marked to market). Top holdings measure from the quarter-end when the name first entered the filer's disclosed top holdings (tagged e.g. Q1 '26); new & added positions measure from this quarter's quarter-end. Based on disclosed 13F snapshots — an approximation of entry, not the manager's actual cost basis. Generated 2026-10-17 · Alpha-Investor tracker